Main menu

RNA liquid biopsy via nanopore sequencing for novel biomarker discovery and cancer early detection


Using Oxford Nanopore sequencing, Peddu and Hill et al. profiled full-length cell-free RNA from blood plasma and uncovered over 270,000 novel transcripts — far beyond the reach of short-read methods. Utilising machine learning models, the team classified early stage oesophageal cancer and precancer with 100% sensitivity and specificity, demonstrating the potential of nanopore sequencing as a non-invasive tool for early cancer detection and monitoring.

'Here we show that nanopore sequencing can be leveraged to comprehensively characterize the vast, unannotated cell-free RNA transcriptome across healthy, precancerous, and cancerous disease states'

Peddu and Hill et al. 2025

Sample type: cell-free RNA from blood plasma

Kit: Ligation Sequencing Kit, Native Barcoding Kit

Authors: Vikas Peddu, Alexander Hill, Sree Lakshmi Velandi Maroli, Connor Mattingly, Joshua M.V. Gardner, Karen H. Miga, Rebecca C. Fitzgerald, Daniel H. Kim

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag